CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,098 shares (to pay taxes)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 10,796 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,578 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,172 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,444 shares (to pay taxes)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Option exercise Director acquired 2,533 shares (option exercise)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,624 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 4,057 shares (to pay taxes)
- 4 Option exercise Director acquired 2,534 shares (option exercise)
- 4 Option exercise Director acquired 2,534 shares (option exercise)
- 4 Option exercise Director acquired 2,534 shares (option exercise)
- 4 Option exercise Director acquired 2,534 shares (option exercise)
Page 5 of 13 · 247 filings